Analysis of telomeric single-strand overhang length in human endometrial cancers
- PMID: 15893755
- DOI: 10.1016/j.febslet.2005.04.021
Analysis of telomeric single-strand overhang length in human endometrial cancers
Abstract
The 3' single-strand telomeric overhang (3'-OH) is a key component of telomere structure. Although telomere length has been well analyzed in a variety of human cancers, no information is available on the 3'-OH length in cancers. In the present study, we examined the 3'-OH length in normal and malignant endometria using telomere-oligonucleotide ligation assay. Although 3'-OH lengths varied among patients, 3'-OH length observed in endometrial cancers was significantly shorter than that found in samples derived from normal endometria (P < 0.001: Student's t-test), suggesting that erosion of 3'-OH length induces impaired telomeric integrity and genomic instability, leading to carcinogenesis. Interestingly, we found that the most aggressive subtypes of endometrial cancers harbored significantly longer 3'-OH length than those with non-aggressive subtypes (P < 0.001: Sheffe's test), suggesting that cancer cells with long 3'-OH length have growth advantage due to their stabilized telomere ends. In contrast, we failed to observe an association between overall telomere length and any clinicopathological characteristics of endometrial cancers. These findings suggest that erosion of 3'-OH length, rather than overall telomere length, play roles in endometrial carcinogenesis. Furthermore, long 3'-OH may serve as a molecular marker for aggressive phenotype of tumors.
Similar articles
-
Erosion of the telomeric single-strand overhang at replicative senescence.Nat Genet. 2003 Apr;33(4):492-6. doi: 10.1038/ng1127. Epub 2003 Mar 24. Nat Genet. 2003. PMID: 12652299
-
Telomeric 3'-overhang length is associated with the size of telomeres.Exp Gerontol. 2008 Apr;43(4):258-65. doi: 10.1016/j.exger.2008.01.005. Epub 2008 Jan 26. Exp Gerontol. 2008. PMID: 18280685
-
The relationship between telomere length and telomerase activity in gynecologic cancers.Gynecol Oncol. 2002 Jan;84(1):81-4. doi: 10.1006/gyno.2001.6483. Gynecol Oncol. 2002. PMID: 11748981
-
Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process.Crit Rev Oncol Hematol. 2008 May;66(2):99-117. doi: 10.1016/j.critrevonc.2007.11.006. Epub 2008 Feb 14. Crit Rev Oncol Hematol. 2008. PMID: 18243729 Review.
-
Telomere dysfunction and telomerase activation in cancer--a pathological paradox?Cytogenet Genome Res. 2007;118(2-4):270-6. doi: 10.1159/000108310. Cytogenet Genome Res. 2007. PMID: 18000380 Review.
Cited by
-
Quantitative telomeric overhang determination using a double-strand specific nuclease.Nucleic Acids Res. 2008 Feb;36(3):e14. doi: 10.1093/nar/gkm1063. Epub 2007 Dec 10. Nucleic Acids Res. 2008. PMID: 18073199 Free PMC article.
-
Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer.Cancer Sci. 2020 May;111(5):1856-1861. doi: 10.1111/cas.14378. Epub 2020 Apr 6. Cancer Sci. 2020. PMID: 32249523 Free PMC article.
-
SIRT1 upregulation promotes epithelial-mesenchymal transition by inducing senescence escape in endometriosis.Sci Rep. 2022 Jul 19;12(1):12302. doi: 10.1038/s41598-022-16629-x. Sci Rep. 2022. PMID: 35853978 Free PMC article.
-
Telomerase and Telomeres in Endometrial Cancer.Front Oncol. 2019 May 17;9:344. doi: 10.3389/fonc.2019.00344. eCollection 2019. Front Oncol. 2019. PMID: 31157162 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources